Drug intelligence / Profile preview

COL1A2-pep1

Development stage
Preclinical
Lead developer
Shanghai Chest Hospital
Modality
Peptides
Administration
Subcutaneous
01

Overview

COL1A2-pep1 is an extracellular matrix (ECM)-derived exerkine (exercise-induced small peptide) being developed by Shanghai Chest Hospital for the prevention and treatment of pathological cardiac remodeling, including cardiac hypertrophy and fibrosis. It was identified via human plasma peptidomics screening of individuals undergoing regular exercise. Mechanistically, COL1A2-pep1 directly binds to the catalytic domain of the cytosolic DNA sensor cyclic GMP-AMP synthase (cGAS), inhibiting its activation and the downstream STING-IRF3-mediated inflammatory cascade. This targeted inhibition of cGAS restores ATP production in cardiomyocytes and activates the PINK1/Parkin signaling pathway, enhancing mitophagy flux, clearing damaged mitochondria, and preventing cytosolic mitochondrial DNA (mtDNA) leakage.

02

Targets

Cyclic GMP–AMP synthasePINK1 (PTEN-induced kinase 1)PRKN (E3 ubiquitin-protein ligase parkin)STING (Stimulator of interferon genes protein)

Beyond the preview

Go deeper on COL1A2-pep1.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on COL1A2-pep1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call